This inventor holds 2 USPTO granted patents. Top assignee: Vanderbilt University. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: Artur W Wamil: Innovator in Neural Injury Repair
Introduction
Artur W Wamil is a notable inventor based in Nashville, TN (US), recognized for his contributions to the field of neural injury repair. He holds 2 patents that focus on innovative treatments for neural injuries, utilizing unique toxins derived from bacteria.
Latest Patents
Wamil's latest patents include methods for the facilitation of repair of neural injury using CM101, a polysaccharide toxin isolated from Group B β-hemolytic Streptococcus bacteria. This treatment aids in re-establishing neuronal connectivity, partially inhibits scar formation, and increases the probability of survival during the critical period following central nervous system injuries. Additionally, his work addresses neural injuries resulting from trauma or surgery, proposing that the GBS toxin can be administered to minimize gliosis and promote neuronal connectivity restoration. This approach also extends to diseases characterized by neuronal degeneration, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Career Highlights
Artur W Wamil is affiliated with Vanderbilt University, where he continues to advance research in neural injury treatments. His innovative work has the potential to significantly impact the field of neurology and improve patient outcomes.
Collaborations
Wamil collaborates with esteemed colleagues, including Carl G Hellerqvist and Barbara D Wamil, contributing to a dynamic research environment focused on neural health.
Conclusion
Artur W Wamil's pioneering work in the treatment of neural injuries showcases his commitment to advancing medical science. His patents reflect a significant step forward in addressing complex neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
